A study by Yang et al. 62 demonstrated mitigation of tau deposits by ex vivo-expanded Tregs, suggesting that Tregs can play a role in reducing tau Alzheimer’s disease pathologies. The gene discussed is MAPT; the disease is Alzheimer disease.